Understanding health equity in patient-reported outcomes.
allergy/immunology
health disparities
health equity
patient-reported outcomes
Journal
The journal of allergy and clinical immunology. In practice
ISSN: 2213-2201
Titre abrégé: J Allergy Clin Immunol Pract
Pays: United States
ID NLM: 101597220
Informations de publication
Date de publication:
20 Apr 2024
20 Apr 2024
Historique:
received:
21
03
2024
revised:
08
04
2024
accepted:
11
04
2024
medline:
23
4
2024
pubmed:
23
4
2024
entrez:
22
4
2024
Statut:
aheadofprint
Résumé
Patient reported outcomes (PROs) are measures of patients' health that are conveyed directly by individual patients. These measures serve as instruments to evaluate the impact of interventions on any aspect of patients' health, from specific symptoms to broader quality-of-life indicators. However, their effectiveness relies on capturing relevant factors accurately. While commonly utilized in clinical trials, PROs extend their influence across healthcare settings, informing clinicians, healthcare payers, regulators, and administrators to guide quality improvement and reimbursement decisions. Neglecting health equity considerations in PRO development and implementation widens health disparities, leading to biased interpretations, medical mismanagement, and poor health outcomes among minoritized groups. To foster equitable healthcare, efforts must focus on considering the values of underrepresented populations in PRO design, addressing barriers to completion, enhancing representation in research, providing cultural competency training for clinicians, and allocating research funding to support health equity research. By addressing these issues, advances can be made towards fostering inclusive, equitable healthcare for all individuals.
Identifiants
pubmed: 38648977
pii: S2213-2198(24)00407-0
doi: 10.1016/j.jaip.2024.04.023
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024. Published by Elsevier Inc.